Balyasny Asset Management LLC Qiagen N.V. Call Options Transaction History

Balyasny Asset Management LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 14, 2023	BUY	$39.13 - $47.24 $7.63 Million - $9.21 Million	195,000 New	195,000 $7.9 Million
Q1 2023 May 15, 2023	BUY	$45.29 - $50.76 $2.94 Million - $3.3 Million	65,000 New	65,000 $2.99 Million
Q3 2022 Nov 14, 2022	BUY	$40.9 - $50.42 $7.98 Million - $9.83 Million	195,000 New	195,000 $8.05 Million
Q1 2022 May 16, 2022	SELL	$42.23 - $54.3 $23.9 Million - $30.7 Million	-566,200 Reduced 80.18%	140,000 $6.86 Million
Q3 2021 Nov 15, 2021	BUY	$46.55 - $56.83 $32.9 Million - $40.1 Million	706,200 New	706,200 $36.5 Million

Q4 2020 Feb 16, 2021	SELL	$46.09 - $54.74 $5.76 Million - $6.84 Million	-125,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$42.51 - $52.42 $484,614 - $597,588	11,400 Added 10.04%	125,000 $6.53 Million
Q2 2020 Aug 14, 2020	BUY	$39.49 - $44.36 $4.49 Million - $5.04 Million	113,600 New	113,600 $4.8 Million

6.76M

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $9.16B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.